[Clinical trials with cefroxadine dry syrup in the treatment of infectious disease of children (author's transl)].

Abstract

Cefroxadine dry syrup was studied clinically and the following results were obtained. The drug was administered to 19 cases of bacterial infections: acute tonsillitis (6), acute bronchitis (6), scarlet fever (2), acute pyelonephritis (4) and acute cystitis (1). The daily dose was about 30 approximately 50 mg/kg except for 1 patient. The drug was given orally, 3 times a day and the duration of administration was from 4 to 11 days. The overall efficacy rate was 100%, i.e., excellent in 17 cases, good in 2 cases. One patient experienced a mild S-GOT elevation and another patient in mild vomiting. From the results obtained in this study, cefroxadine dry syrup seems to be useful in the treatment of infectious diseases of children.

• Authors: S Furukawa, T Okada, F Hirao
• Journal: The Japanese journal of antibiotics (Jpn J Antibiot) Vol. 34 Issue 12 Pg. 1697-702 (Dec 1981) ISSN: 0368-2781 [Print] Japan
• PMID: 7038188 (Publication Type: Clinical Trial, Journal Article)

Chemical References

• Cephalosporins
• Dosage Forms
• cefroxadine
• Cephradine

Topics

• Bacterial Infections (drug therapy, microbiology)
• Cephalosporins (therapeutic use)
• Cephradine (administration & dosage, adverse effects, analogs & derivatives, therapeutic use)
• Child
• Child, Preschool
• Clinical Trials as Topic
• Dosage Forms
• Drug Evaluation
• Female
• Humans
• Infant
• Male